ABC - AmerisourceBergen Corporation

NYSE - Nasdaq Real Time Price. Currency in USD

AmerisourceBergen Corporation

1 West First Avenue
Conshohocken, PA 19428-1800
United States
610 727 7000

IndustryMedical Distribution
Full Time Employees39,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Steven H. CollisChairman, Pres & CEO5.49M10.88M1961
Mr. James F. Cleary Jr.Exec. VP & CFO2.12MN/A1963
Dr. Robert P. Mauch Ph.D., PharmDExec. VP & COO2.32M3.76M1967
Ms. Gina K. ClarkExec. VP and Chief Communications & Admin. Officer1.68M2.75M1957
Ms. Silvana BattagliaExec. VP & Chief HR Officer1.58MN/A1967
Mr. Lazarus KrikorianSr. VP, Chief Accounting Officer & Corp. ControllerN/AN/A1965
Bennett S. MurphySr. VP of Investor RelationsN/AN/AN/A
Ms. Kathy H. GaddesExec. VP & Chief Compliance OfficerN/AN/A1963
Ms. Elizabeth S. CampbellExec. VP & Chief Legal OfficerN/AN/A1975
Mr. John G. ChouExec. VP and Special Advisor to the Chairman & CEON/AN/A1956
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Corporate Governance

AmerisourceBergen Corporation’s ISS Governance QualityScore as of May 30, 2023 is 4. The pillar scores are Audit: 4; Board: 3; Shareholder Rights: 6; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.